Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Astellas Pharma takes third spot in retail investor "buy" rankings on Minkabu
Astellas Pharma Inc. <4503> ranked third in buy sentiment among retail investors on the Minkabu platform as of 11:00 a.m. on April 28.
Astellas Pharma shares fell for a sixth straight session in Tokyo on April 28. The drugmaker announced consolidated operating profit of 382.63 billion yen for the fiscal year ended March 2026 after the April 27 market close, a more than nine-fold surge from the previous year. While strong growth in key strategic products and robust guidance for the fiscal year ending March 2027?including a dividend hike to 80 yen from 78 yen?fueled buy sentiment, the stock struggled.
The stock price remained sluggish following the earnings report as investors locked in profits on the news.
Source: MINKABU PRESS
*Translated by generative AI. Click here for the original article.
Related Articles
Tokyo stocks fall further in early afternoon trading, Nikkei average extends losses
"Defense" ranks 7th as removal of "5 categories" spurs renewed momentum for related companies
Tokyo stocks fall in morning session on profit-taking in major semiconductor stocks
Active stocks on the 28th (morning session) - PENTA-OCEAN CONSTRUCTION, KITAGAWA SEIKI, inspec
Major headlines in morning trading on the 28th
NS Solutions shares firm on record profit, dividend hike forecasts
MIKUNI shares slide on earnings delay following overseas subsidiary misconduct
SKY Perfect JSAT Corporation rebounds with expanded gains on equity-method affiliate's MOU with Airbus subsidiary
Tokyo stock gainers outnumber losers as of 11 a.m., 1,181 vs 345
Shanghai Composite Index opens at 4,076.1431 on the 28th, down 10.2011 points